CompletedPhase 3

Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery

United States49 participantsStarted 2019-05-21

Plain-language summary

1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following ACL reconstruction surgery. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following ACL reconstruction surgery.

Who can participate

Age range18 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients between 18 and 89 years old * Patients undergoing primary anterior cruciate ligament (ACL) reconstruction surgery Exclusion Criteria: * Patients below age 18 or above age 89 * Illiterate or non-English speaking individuals * Patients with contraindications to Ketorolac * History of chronic alcohol or drug abuse * Chronic use of psychotropic or analgesic drugs * Known peptic ulcer disease or bleeding diasthesis * Renal dysfunction (estimated glomerular filtration rate \< 50 mL/min/1.73m2) * Breastfeeding women * Pregnant women

What they're measuring

Postoperative Visual Analogue Scale Scores

Timeframe: Up to 8 weeks postoperative

Trial details

NCT IDNCT04246554

SponsorUniversity Hospitals Cleveland Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-10-09

Results submitted2021-10-18

View on ClinicalTrials.gov More ACL Injury trials